Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/27/2025

5-Fluorouracil Eye Drops for Ocular Surface Squamous Neoplasia

Primary Indication

  • Ocular surface squamous neoplasia (OSSN) is the main indication for 5-FU eye drops, as confirmed by multiple ophthalmology guidelines 1
  • 5-FU is one of several topical chemotherapeutic agents that can be used either as primary therapy or as adjunctive treatment following surgical excision of OSSN 1

Treatment Considerations

  • 5-FU is particularly useful for patients where tissue preservation is important 1

Clinical Pearls

  • DPD (dihydropyrimidine dehydrogenase) testing should be considered before initiating 5-FU treatment to identify patients at risk for systemic toxicity 2
  • For patients with partial DPD deficiency, alternative treatments should be considered, or if 5-FU must be used, smaller areas should be treated with close monitoring 2

REFERENCES

2

Dihydropyrimidine Dehydrogenase Testing for Cancer Treatment [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025